GlassScriptPhysician profile
Jaime L Silva
NPI 1689634883
$27,543.68
in general payments reported to CMS, 2019-2025
40 companies · $3,599 in 2025
The $3,599 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,730 · 2020: $1,288 · 2021: $3,914 · 2022: $2,691 · 2023: $3,425 · 2024: $4,896 · 2025: $3,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,640 · Travel and Lodging: $4,205 · Education: $75.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,640.27 |
| Travel and Lodging | $4,204.61 |
| Education | $75.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,855.53 | 2019-2025 | Xact, Diamondback Peripheral, Perclose Proglide |
| Medtronic, INC. | $3,673.38 | 2021-2025 | Venaseal, Corevalve Evolut R, Endurant Iis |
| Biotronik INC. | $2,770.79 | 2019-2025 | Plexa Promri, Sentus, Solia |
| Abiomed | $2,507.42 | 2019-2025 | |
| Penumbra, INC. | $1,876.69 | 2022-2025 | Indigo System |
| Janssen Pharmaceuticals, INC | $1,364.13 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $1,305.06 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Corindus INC. | $1,002.82 | 2019 | |
| Bard Peripheral Vascular, INC. | $990.83 | 2019-2020 | |
| Medtronic Vascular, INC. | $770.81 | 2019-2020 | |
| Intuitive Surgical, INC. | $710.15 | 2021-2023 | Da Vinci Surgical System |
| Siemens Medical Solutions USA, INC. | $705.60 | 2019-2023 | Artis Icono Floor |
| E.R. Squibb & Sons, L.L.C. | $545.39 | 2019-2024 | Eliquis, Camzyos |
| Cardiovascular Systems INC. | $484.80 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $442.73 | 2019-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $382.85 | 2019-2024 | |
| Philips North America LLC | $358.10 | 2021-2024 | (Dd1) Duo Hybrid |
| Novartis Pharmaceuticals Corporation | $321.74 | 2020-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $311.30 | 2019-2025 | Lifevest |
| Chiesi USA, INC. | $303.47 | 2019-2025 | Kengreal |
| Amarin Pharma, INC. | $294.59 | 2019-2020 | |
| Novo Nordisk INC | $279.45 | 2022-2025 | Wegovy |
| Heartflow, INC. | $221.37 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $192.03 | 2025 | |
| Merck Sharp & Dohme LLC | $141.83 | 2021-2025 | Verquvo |
| Ge Healthcare | $121.61 | 2019 | |
| Cvrx, INC. | $117.62 | 2025 | Barostim Neo System |
| Viatris Specialty LLC | $114.65 | 2025 | Yupelri |
| Angiodynamics, INC. | $90.84 | 2024 | Auryon Laser System 100-120 Vac |
| Cook Medical LLC | $78.72 | 2023 | Zilver Vena |
| Cardiva Medical, INC. | $43.51 | 2023 | Cardiva Vascade 6/7f Vcs |
| Amgen INC. | $27.65 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $24.23 | 2023 | Inpefa |
| Pfizer INC. | $23.05 | 2023 | |
| W. L. Gore & Associates, INC. | $20.67 | 2021 | |
| Inspire Medical Systems, INC. | $17.71 | 2025 | Inspire |
| Lilly USA, LLC | $13.82 | 2023 | Mounjaro |
| Preventice Services, LLC | $13.41 | 2021 | |
| Xeris Pharmaceuticals, INC. | $12.02 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.